[HTML][HTML] Individualized antibiotic dosage regimens for patients with augmented renal clearance
AX Shi, Q Qu, HH Zhuang, XQ Teng, WX Xu… - Frontiers in …, 2023 - frontiersin.org
Objectives: Augmented renal clearance (ARC) is a state of enhanced renal function
commonly observed in 30%–65% of critically ill patients despite normal serum creatinine …
commonly observed in 30%–65% of critically ill patients despite normal serum creatinine …
[HTML][HTML] Pharmacokinetics of antibacterial agents in the elderly: the body of evidence
OI Butranova, EA Ushkalova, SK Zyryanov… - Biomedicines, 2023 - mdpi.com
Infections are important factors contributing to the morbidity and mortality among elderly
patients. High rates of consumption of antimicrobial agents by the elderly may result in …
patients. High rates of consumption of antimicrobial agents by the elderly may result in …
Plasma protein binding of ceftriaxone in critically ill patients: can we predict unbound fractions?
TMJ Ewoldt, S Bahmany, A Abdulla… - Journal of …, 2023 - academic.oup.com
Background Standard antibiotic dosing is not suitable for critically ill patients, due to altered
pharmacokinetics (PK) in these patients. Knowledge of protein binding is important for …
pharmacokinetics (PK) in these patients. Knowledge of protein binding is important for …
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis
In the present study, population pharmacokinetic (PK) analysis was performed based on
meropenem data from a prospective study conducted in 114 critically ill patients with a wide …
meropenem data from a prospective study conducted in 114 critically ill patients with a wide …
Meropenem pharmacokinetics and target attainment in critically ill patients
Y Gan, X Meng, N Lei, H Yu, Q Zeng… - Infection and Drug …, 2023 - Taylor & Francis
Purpose This study aimed to investigate the pharmacokinetics and target attainment of
meropenem and compare the effect of meropenem dosing regimens in critically ill patients …
meropenem and compare the effect of meropenem dosing regimens in critically ill patients …
[HTML][HTML] Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning …
A Wieringa, TMJ Ewoldt, RN Gangapersad, M Gijsen… - Antibiotics, 2023 - mdpi.com
In the intensive care unit (ICU), infection-related mortality is high. Although adequate
antibiotic treatment is essential in infections, beta-lactam target non-attainment occurs in up …
antibiotic treatment is essential in infections, beta-lactam target non-attainment occurs in up …
Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis
Introduction Population pharmacokinetic studies of β-lactam antimicrobials in critically ill
patients derive models that inform their dosing. In non-linear mixed-effects modelling …
patients derive models that inform their dosing. In non-linear mixed-effects modelling …
Population pharmacokinetics/pharmacodynamics and clinical outcomes of meropenem in critically ill patients
A Boonpeng, S Jaruratanasirikul… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Several pathophysiological changes can alter meropenem pharmacokinetics in critically ill
patients, thereby increasing the risk of subtherapeutic concentrations and affecting …
patients, thereby increasing the risk of subtherapeutic concentrations and affecting …
Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia
Objectives Critical illness reduces β-lactam pharmacokinetic/pharmacodynamic (PK/PD)
attainment. We sought to quantify PK/PD attainment in patients with hospital-acquired …
attainment. We sought to quantify PK/PD attainment in patients with hospital-acquired …
Meropenem pharmacokinetic/pharmacodynamic target attainment and clinical response in ICU patients: A prospective observational study
E Helset, V Cheng, H Sporsem… - Acta …, 2024 - Wiley Online Library
Background Several studies report lack of meropenem pharmacokinetic/pharmacodynamic
(PK/PD) target attainment (TA) and risk of therapeutic failure with intermittent bolus infusions …
(PK/PD) target attainment (TA) and risk of therapeutic failure with intermittent bolus infusions …